Alpha DNA Investment Management’s Verve Therapeutics VERV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-37,640
Closed -$500K 248
2024
Q1
$500K Buy
+37,640
New +$500K 0.18% 150